Medpacto acquires patent for cancer antibody treatment targeting BAG2

Medpacto acquires patent for cancer antibody treatment targeting BAG2 Patent related to antibody treatment technology capable of treating cancer based on BAG2 expression [April 13, 2021] Medpacto (CEO Seong-Jin Kim) announced on the 13th that it has registered a domestic patent for BAG2 antibody treatment. According to this patent registration, Medpacto will have exclusive rights to the antibody treatment technology targeting BAG2 by 2039. This patent relates to the core technology of MA-B2, Medpacto's follow-up pipeline, and relates to an antibody treatment targeting the cancer metastasi..........

원문링크 : Medpacto acquires patent for cancer antibody treatment targeting BAG2